Buy One, Get One FreeAdd a GHK-Cu vial and your second one is on usShop GHK-Cu

GHK-Cu: Research Chemistry and Literature

GHK-Cu is the copper(II) complex of glycyl-L-histidyl-L-lysine, a tripeptide of the sequence Gly-His-Lys. The free peptide has the formula C14H24N6O4 and a mass near 340 daltons. Copper is held by three nitrogen donors: the N-terminal amine, the deprotonated amide nitrogen of the glycyl-histidyl bond, and the imidazole nitrogen of the histidine side chain. The affinity of the tripeptide for the metal is close to that of the amino-terminal copper transport site of serum albumin, which is the comparison drawn in the earliest characterisation work. The side-chain amine of the lysine residue takes no part in coordination and leaves the complex cationic near neutral pH.

Catalogue material is prepared by solid-phase synthesis and complexed with a copper salt after cleavage and purification. The product is a blue lyophilised solid, the colour arising from ligand field absorption of the bound metal in the visible region. Stoichiometry is worth checking against whatever record a given reference uses. PubChem holds separate entries for the free tripeptide and for a copper complex written with two peptide units per metal centre, while much of the commercial literature quotes a one-to-one formula. None of that is settled by the name alone, so the certificate for a given lot is the operative document.

Reference data

CAS number
49557-75-7
Chemical formula
C14H24CuN6O4
Molar mass
403.92 g/mol
Shelf life
24 months

Origin and identification

The sequence was not designed. Pickart and Thaler reported it in Nature New Biology in 1973, having tracked a growth-modifying fraction through human plasma and narrowed it to a small peptide. The starting observation was a difference between plasma drawn from younger and from older donors in hepatocyte culture. Fractionation of the albumin pool led to the tripeptide, and the assignment was confirmed against synthetic material.

The Gly-His-Lys triplet also occurs internally in the alpha-2 chain of type I collagen. That observation is the standard argument for a matrix origin, the peptide being liberated by proteolysis of collagen during tissue remodelling rather than produced as a discrete gene product. It is a plausible account and it is repeated across the review literature, though it rests on sequence coincidence more than on direct isolation from digested collagen.

The complex is indexed under several names, copper tripeptide-1 among them. PubChem carries the free peptide as CID 73587 and a copper complex as CID 133697840. Neither identifier fixes a metal ratio on its own, so analytical work on incoming material starts from the peptide and treats copper content as a separate question.

Preclinical research context

Most of the primary literature is cell culture work on fibroblasts. Maquart and colleagues measured collagen synthesis in human fibroblast monolayers exposed to the complex and reported stimulation that was independent of any change in cell number, which rules out a simple proliferation artefact. Later work from the same group examined matrix metalloproteinase-2 in conditioned media and found the response was reproduced by copper ions but not by the uncomplexed tripeptide. Those two papers set the shape of the field: matrix protein output and matrix turnover enzymes, measured in vitro, with the metal doing part of the work.

A second strand uses damaged or stressed cells. Pollard and co-workers compared normal human dermal fibroblasts with irradiated fibroblasts, following population doubling times and measuring basic fibroblast growth factor and vascular endothelial growth factor output by immunoassay. The irradiated cultures were the point of interest, since they divided slowly and the comparison was against their own untreated controls rather than against the normal line.

More recent reports extend the panel to other matrix proteins and to ex vivo tissue. Jiang and colleagues examined collagen IV expression in fibroblast culture and in human skin explants. Review articles, notably the 2015 survey by Pickart and colleagues, collate transcriptional profiling and pathway analyses across cultured human cell lines and describe a broad response rather than a single molecular target. Rodent wound and tissue models appear in that secondary literature as well. The primary sources are the ones to read, because summary articles in this area tend to compress in vitro observations into claims the underlying experiments do not support.

Analytical characterisation

Chromatographic purity is determined by reverse-phase HPLC on a C18 stationary phase, using a water and acetonitrile gradient acidified with trifluoroacetic acid and detection in the low ultraviolet where the amide backbone absorbs. The acid matters. Under those conditions copper is stripped from the peptide on column, so what elutes is the free tripeptide and the figure reported is the purity of the peptide component. Copper content is a separate determination and does not follow from the chromatogram.

Mass spectrometry confirms that the material carries the mass the sequence predicts. Electrospray ionisation of the free peptide gives the expected protonated species. Where the intact complex survives ionisation, the copper isotope pattern is diagnostic, since the two stable isotopes occur near a seven to three ratio and produce a signature no organic impurity mimics. Sequence-level confirmation is available by tandem fragmentation when a batch warrants it.

Each lot is tested by Janoshik Analytical, an independent laboratory, and the certificate is filed against the lot number rather than against the product line. The certificate reproduces the chromatogram and the mass spectrum, not only the summary figures, so the trace can be read directly. A certificate that cannot be tied to a specific lot is of limited use and should be treated as such.

Handling and storage

The lyophilised complex tolerates ambient conditions in transit. Short periods at room temperature during carriage do not compromise the solid, which is why cold-chain shipping is not used for these items. On arrival the vial should be moved to minus 20 degrees Celsius. Held there, sealed and dry, the solid is stable over long periods.

Light is the second variable. Keep vials in their original packaging or in an opaque container. Copper complexes absorb across the visible range, and prolonged illumination is an avoidable risk, particularly for material already in solution. Working stocks belong out of direct light on the bench.

Reconstituted material belongs at 2 to 8 degrees Celsius and should be regarded as short-lived relative to the dry solid. Repeated freezing and thawing degrades peptides through concentration effects at the advancing ice front, so divide the solution into single-use aliquots before any of it goes to the freezer. Label each aliquot with the lot and the date it was made up. Discard anything that has turned cloudy or thrown a precipitate.

References

  1. Tripeptide in human serum which prolongs survival of normal liver cells and stimulates growth in neoplastic liver
  2. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+
  3. The tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ stimulates matrix metalloproteinase-2 expression by fibroblast cultures
  4. Effects of copper tripeptide on the growth and expression of growth factors by normal and irradiated fibroblasts
  5. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration
  6. Synergy of GHK-Cu and hyaluronic acid on collagen IV upregulation via fibroblast and ex-vivo skin tests
  7. GHK-Cu, PubChem Compound Summary CID 133697840
  8. glycyl-L-histidyl-L-lysine, PubChem Compound Summary CID 73587

Related compounds

This page summarises published laboratory research for reference purposes. Materials described are supplied for in vitro and analytical research use only. Not for human or veterinary consumption.